Cassandra Nan
Overview
Explore the profile of Cassandra Nan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wark P, Hew M, Xu Y, Ghisla C, Nguyen T, Erdemli B, et al.
J Asthma
. 2022 Jul;
60(4):727-736.
PMID: 35844195
Background: In Australia, the regional prevalence of difficult-to-treat asthma is unknown. We aimed to describe regional variation in difficult-to-treat asthma prevalence and oral corticosteroid (OCS) use. Methods: In this retrospective,...
2.
Lehtimaki L, Arvidsson M, Erdemli B, Nan C, Nguyen T, Samant A, et al.
Eur Clin Respir J
. 2022 May;
9(1):2066815.
PMID: 35529252
Oral corticosteroids (OCS) are often prescribed to patients with asthma that remains uncontrolled with maintenance therapy. We performed a real-world analysis to describe the geographic distributions of patients with asthma...
3.
Nan C, Schmidt O, Lindner R, Ilgin Y, Schultz T, Gylvin L, et al.
J Asthma
. 2021 Jan;
59(4):791-800.
PMID: 33492176
Objective: To improve understanding of real-world asthma treatment and inform physician education, we evaluated regional variation in asthma prevalence and oral corticosteroid (OCS) use across Germany. Methods: We developed a...
4.
Bloom C, Cabrera C, Arnetorp S, Coulton K, Nan C, van der Valk R, et al.
Adv Ther
. 2020 Jul;
37(10):4190-4208.
PMID: 32720299
Introduction: Patients with asthma typically increase short-acting β-agonists (SABA) use with worsening symptoms. Excessive SABA use may lead to a higher risk of adverse outcomes. We evaluated, in a large...
5.
Tran T, King E, Sarkar R, Nan C, Rubino A, OLeary C, et al.
Eur Respir J
. 2020 Mar;
55(6).
PMID: 32165402
Oral corticosteroids (OCS) are used to manage asthma exacerbations and severe, uncontrolled asthma, but OCS use is associated with adverse effects. We aimed to describe the patterns of OCS use...
6.
Janson C, Menzies-Gow A, Nan C, Nuevo J, Papi A, Quint J, et al.
Adv Ther
. 2020 Jan;
37(3):1124-1135.
PMID: 31981105
Introduction: Globally, individuals with asthma tend to overrely on short-acting β-agonists (SABAs) and underuse inhaled corticosteroids, thereby undertreating the underlying inflammation. Such relief-seeking behavior has been reinforced by long-standing treatment...
7.
Cabrera C, Nan C, Lindarck N, Beekman M, Arnetorp S, van der Valk R
Eur Respir J
. 2019 Dec;
55(2).
PMID: 31806716
No abstract available.
8.
Nan C, Shaefer M, Urbaityte R, Oyee J, Hopking J, Ragone L, et al.
Open Forum Infect Dis
. 2018 May;
5(5):ofy086.
PMID: 29766019
Background: Some observational studies and randomized controlled trials (RCTs) have suggested an association between abacavir (ABC) use and myocardial infarction (MI), whereas others have not. Methods: This pooled analysis of...
9.
Ross E, Munoz F, Edem B, Nan C, Jehan F, Quinn J, et al.
Vaccine
. 2017 Nov;
35(48 Pt A):6483-6491.
PMID: 29150053
No abstract available.
10.
Campisi E, Rosini R, Ji W, Guidotti S, Rojas-Lopez M, Geng G, et al.
Front Microbiol
. 2016 Aug;
7:1265.
PMID: 27574519
Neonatal invasive disease caused by group B Streptococcus (GBS) represents a significant public health care concern globally. However, data related to disease burden, serotype distribution, and molecular epidemiology in China...